Compare ALKS & FORM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALKS | FORM |
|---|---|---|
| Founded | 1987 | 1993 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 7.1B |
| IPO Year | 2012 | 2002 |
| Metric | ALKS | FORM |
|---|---|---|
| Price | $42.48 | $125.00 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 14 | 9 |
| Target Price | $43.43 | ★ $98.25 |
| AVG Volume (30 Days) | 1.9M | ★ 2.0M |
| Earning Date | 05-05-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ 0.26 |
| Revenue | ★ $1,475,899,000.00 | N/A |
| Revenue This Year | $24.26 | $19.43 |
| Revenue Next Year | $4.47 | $7.31 |
| P/E Ratio | ★ N/A | $499.85 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $25.17 | $27.00 |
| 52 Week High | $40.79 | $159.09 |
| Indicator | ALKS | FORM |
|---|---|---|
| Relative Strength Index (RSI) | 78.32 | 45.44 |
| Support Level | $27.65 | $112.31 |
| Resistance Level | N/A | $158.36 |
| Average True Range (ATR) | 1.46 | 9.85 |
| MACD | 0.33 | -1.16 |
| Stochastic Oscillator | 97.25 | 26.91 |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
FormFactor Inc is a provider of electrical and optical test and measurement technologies along the full semiconductor product lifecycle - from characterization, modeling, reliability, and design de-bug, to qualification and production test.. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.